Komori
Qol Holdings (3034) · InitiativeAdvanced

Strengthening Sales Capabilities to Secure CRO Engagements

First written in FY2019-Q1. 7 of 11 entries say "Advanced", first in FY2019. Latest entry: 2026-08-07.

11entries
9years
3from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2020-Q1AdvancedFY2024-Q3 – 2026-08-072018: 220182019: 320192020: 020202021: 020212022: 020222023: 020232024: 120242025: 120252026: 42026
Same theme, other companies
Expanding the Evidence Solutions BusinessA theme 9 companies write about · 2 as a headwind · 10 as a tailwind

The whole theme swung hardest in 2020: 1 of 8 companies on the "Worse" side.

2 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. 2026-08-07AdvancedEarnings

    「Using Klink Cloud Co., Ltd.’s system, we will expand orders for testing and clinical trials in the food sector.」

    The CRO business’s policy of expanding orders was made concrete through the use of Klink Cloud’s system for food testing and clinical trials.
  2. FY2026AdvancedAnnual report

    「In November 2025, the CRO business, which undertakes development work for pharmaceuticals, food products and other items, brought クリンクラウド株式会社 into the group. クリンクラウド株式会社 provides EDC used in clinical trials and clinical research for pharmaceutical development. In addition to expanding clinical trials and clinical research in pharmaceutical development, we will leverage the resulting synergies to drive further business expansion by providing support using EDC for food testing.」

    The CRO business expanded into support for clinical trials, clinical research and food testing using EDC through クリンクラウド株式会社 becoming part of the group in November 2025.
  3. FY2026-H1AdvancedAnnual report

    「The CRO business, which undertakes development work for pharmaceuticals, food products and other items, will expand at アポプラスステーション株式会社, driven mainly by an increase in orders for food testing.」

    The CRO business is expanding, driven mainly by an increase in orders for food testing.
  4. FY2024-Q3AdvancedAnnual report

    「The contract development business for pharmaceuticals, food products and other items is expanding, driven mainly by an increase in orders for food testing.」

    The contract development business for pharmaceuticals, food products and other items is expanding due mainly to an increase in orders for food testing.
  5. FY2020-Q1RestatedAnnual report

    「In the CRO business, revenue is increasing as a result of strengthening sales capabilities to increase the number of projects won.」

    The company continues initiatives to strengthen sales capabilities in the CRO business, aiming to increase the number of projects won and revenue.
  6. FY2019AdvancedAnnual report

    「In the CRO business, revenue is increasing as a result of strengthening sales capabilities to increase the number of projects won and strengthening the organizational structure.」

    In addition to strengthening sales capabilities, the company strengthened its organizational structure, contributing to higher CRO business revenue.
  7. FY2019-Q3RestatedAnnual report

    「In the CRO business, revenue is increasing as a result of strengthening sales capabilities to increase the number of projects won.」

    The company continues to strengthen sales capabilities to increase the number of projects won in the CRO business and reported higher revenue.
  8. FY2019-Q2RestatedAnnual report

    「In the CRO business, we are working to strengthen sales capabilities to increase the number of projects won.」

    The company continues to strengthen sales capabilities to increase the number of projects won in the CRO business.
  9. FY2019-Q1First statedAnnual report

    「In the CRO business, we are working to strengthen sales capabilities to increase the number of projects won.」

    The company has initiated and explicitly identified strengthening sales capabilities as a measure to increase the number of projects won in the CRO business.
Moved together

"Improving Convenience Through ICT" moved the same way as this thread, in the same document, in 6 of its 11 moves.

655555★123456
  1. ★This thread
  2. 1Improving Convenience Through ICT6×
  3. 2Business Expansion through M&A5×
  4. 3Track Record of Expanding the Health Insurance Pharmacy Network5×
  5. 4Insurance Pharmacy Store Base5×
  6. 5Selective Focus and Concentration in the BPO Outsourcing Business5×
  7. 6Improving Market Share by Increasing Staffing in the CSO Business5×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Qol Holdings's next results are scheduled for 2026-11-05. Read the earnings preview It last moved in the Earnings of 2026-08-07: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.